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Several lymphocyte responses occur in discrete clusters of dendritic cells (DC)'
and T cells (1-8). The capacity to form these aggregates is not simply the result
of antigen presentation and recognition . Macrophages and B cells, which present
antigen to primed T cells (3-5), do not cluster resting lymphocytes (1-6). It has
been proposed that DC firstbind to T cells by an antigen-independent mechanism
(5). Antigen-specific lymphocytes are then selected and activated within the DC-
T cell cluster.
Lymphocyte function-associated antigen (LFA-1) and CD4 are found on the
surface of most helper T lymphocytes and may be accessory molecules for the
binding of T lymphocytes to APC, particularly low-avidity T cells (9-11). It is
clear that mAb to these molecules inhibit T cell responses (12-16), yet there has
been little direct analysis of the idea that anti-LFA-1 or CD4 block APC-T
binding in primary systems. Given the prior work identifying DC-T cell inter-
actions in vitro, it is feasible to pursue the mechanism whereby anti-LFA-1 and
CD4 inhibit mitogenesis and to determine whether these molecules are required
for DC-T clustering.
We find that mAb to LFA-1 and CD4 do not alter the initial clustering of DC
with small and large CD4+ lymphocytes in the MLR. Both mAb block the
function of clusters subsequently. Anti-LFA-1 interferes with the stability of DC-
T clusters, whereas anti-CD4 blocks IL-2 release without altering the stability of
DC-T conjugates.
Materials and Methods
T Cells.
￿
Lymphocytes were prepared from spleen suspensions, or from mixtures of
spleen and mesenteric lymph node, from (C X D2)Fl (H-2 d X d), (B6 X D2)F, (H-2 b X
d), and B6.H-2k mice (The Trudeau Institute, Saranac Lake, NY). Mice of both sexes,
6-12 wk of age, were used. Unprimed CD4* T cells were nylon wool nonadherent
populations that were treated with anti-CD8 (HO 2.2 anti-Lyt-2.2, American Type Culture
Collection [ATCC] Rockville, MD) and anti-la mAb (B21-2, TIB 229; 10-2.16, TIB 93;
or M5/114, TIB 120; ATCC) and fresh rabbit serum (2). Antigen-sensitized T blasts and
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memory cells were obtained from the primary MLR as described (3, 17) . The primed T
cells were alloantigen-specific in assays that measured APC-T cell binding (5, and see
below) and the restimulation of IL-2 release (3, 5, 17).
DC-T Cell Interactions in Primary Responses. Unless stated in Results, MLRs were
initiated by culturing 5 x 10' splenic DC with 5 x 106 allogeneic CD4+, la- T cells in 1
ml of medium in 16-mm-diam tissue culture wells. The medium was 10% FCS-RPMI
1640 supplemented with 5 x 10-5 M 2-ME and 20 wg/ml gentamicin. mAb were added
at the doses and times indicated in Results. At 20-40 h (see Results), the cultures were
applied to shallow Percoll gradients to separate cluster and noncluster fractions (2, 3).
Isolated clusters were cultured in 6-mm microtest wells (3 x 10' cells in 200 A1) or in 16-
mm macrowells (3 x 105 cells in 1 ml). T cell proliferation was monitored by adding ['H]
-TdR (4 uCi/ml) for 8-12 h. T cell growth factor in the medium (here termed IL-2
because growth factor activity was inhibited by an anti-IL-2 mAb, unpublished observa-
tions) was measured by adding a limiting dose of medium (6-50%, vol/vol) to 3 x 10'
Con A-induced blasts in 100 jut of total volume, and by measuring [8H]TdR uptake at
18-24 h (3, 17). All results are means of triplicates. Standard deviations were 5-20% and
are not shown.
To monitor entry of APC into clusters, bulk spleen adherent cells (macrophages and
DC) or enriched DC (2) were labeled with a fluorescent, stable, nontoxic carbocyanine
dye (diI perchlorate, Molecular Probes, Inc., Junction City, OR) and added to the T cells
(18). Spleen adherent cells were obtained by an improved technique developed by Dr. A.
Nusrat (The Rockefeller Univ.). Spleen cells (40-80 x 107 nucleated cells) were suspended
in 15-ml conical polypropylene tubes (Sarstedt, Inc., Piscataway, NJ) in 5.5 ml of 70%
Percoll (Pharmacia Fine Chemicals, Piscataway, NJ) diluted with 3% FCS and PBS. The
column was overlaid with 1 .5 ml of culture medium and spun to equilibrium (18 min at
1,800 g at 4°C in an RC3b centrifuge [DuPont Sorvall, Newtown, CT]). 30-50% of the
white cells floated, and this low-density fraction was harvested, washed twice, and adhered
at 108 cells/100-mm petri dish. Nonadherent cellswere dislodged by gently pipetting over
the entire adherent layer. Adherent cells were cultured overnight, whereupon most of
the DC were nonadherent, and most macrophages could be dislodged by pipetting. 60-
80% of the spleen adherent cellsand all ofthe DC (30% of the total adherent preparation)
were stained with the B21-2 mAb to class 11 MHC antigens (1) and a polyclonal FITC
mouse anti-rat Ig (605-540 ; Boehringer Mannheim Biochemicals, Indianapolis, IN). The
adherent cells were labeled with diI, 20 wg/ml in medium for 1 h at 37°C in 15-ml
polypropylene tubes. The cells were reapplied to 16-mm-diam wells for 1 h and separated
into readherent (macrophages) and nonadherent (>90% DC) fractions (1). Allogeneic T
cells were added and the cultures were followed at daily intervals. The presence of the
dye permitted enumeration of APC in cluster and noncluster fractions on a hemocytom-
eter (18), as well as visualization of APC-T cell interactions in live cultures with an
inverted microscope equipped for epifluorescence (Diaphot; Nikon, Inc., Garden City,
NY).
DC-T Cell Interactions with Antigen-sensitized TCells.
￿
Rapid (10-20 min) binding assays
were set up with graded doses of DC and a single dose (usually 105) T blasts or memory
cells. The latter were derived from the MLR and were tagged with fluorescein diacetate
as described (5). DC and T cellswere sedimented at 4°C and then kept on ice or at 37'C .
10-60 min later (the results were similar over this time period), the cell pellets were
resuspended twice with a 100-/.1 Eppendorf pipette. The number of nonclustered T cells
were counted, because the DC-T clusters were typically multicellular and difficult to
count. DC-T binding was antigen-dependent on ice, because >80% of the blasts bound
to allogeneic but not syngeneic or third-party DC. In contrast, binding was antigen-
independent at 37°C.
mAb. A large panel of hybridoma culture supernatants (ATCC) were tested for
blocking activity in the MLR (see Tables I and V, Results). The culture supernatants
contained 50-150 ,ug/ml of rat Ig as titered in an ELISA. None of the mAb agglutinated
T cells or T lymphoblasts in short- (<1 h) or long- (4 d) term culture. Reactivity of the
mAb with DC and with T cells was monitored by indirect immunofluorescence againINABA AND STEINMAN
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FIGURE 1 .
￿
Relative capacity of macrophages andDC to aggregate T cells . Macrophages (left)
and DC (right) were labeled with a fluorescent carbocyanine dye and mixed with allogeneic
CD4* T lymphocytes . At 1-4 d (day 2 is shown here), the cultures were examined with an
inverted microscope by phase-contrast (top) and fluorescence (bottom) microscopy . Note that
the fluorescent macrophages, some of which can be detected by phase contrast (arrows), do
not form clusters whereas the DC do. -5% of the clustered cells are DC (see reference 18 and
Table 1) . x100.
using a polyclonal FITC mouse anti-rat Ig . The mAb to CD4 and to LFA-1 produced
optimal staining at ^-3%, vol/vol, and stained most small and large lymphocytes in the
DC-Lyt-2- MLR. The mAb produced a uniform ring pattern of fluorescence without
capping even after 24-h in culture . DC stained strongly with anti-la, weakly with anti-
LFA-1, but not at all with anti-CD4 .
Results
Clustering of CD4+ T Cells with DC but Not Macrophages in the MLR .
￿
The
availability of carbocyanine dyes as stable nontoxic fluorescent labels has made
it possible to monitor the formation of APC-T cell clusters more directly than
in prior experiments (1-4) . When DC were cultured with allogeneic T cells,
most of the dye-labeled DC were in DC-T aggregates within 24 h (Fig . 1, right)
and large numbers of lymphoblasts were produced (3, 5). When allogeneic
macrophages were tested, no aggregates were seen during 5 d of culture (Fig . 1,
left) and no T cell proliferation occurred (3). However, polyclonal mitogens,
such as anti-CD3 and Con A, mediated the formation ofT cell clusters around
most of the macrophages (not shown) .
Quantitative studies confirmed that most of the DC in the culture had aggre-
gated with the CD4+ T cells within 24 h (Table I, legend) . Two observations
suggested that the majority of antigen-responsive cells also had aggregated .
Mixing clusters and nonclusters did not increase the proliferative response
beyond that seen with clusters alone (Table 1), and the nonclusters responded
normally to rechallenge by a third party but had <10% of the response to the
original stimulating DC (see Fig. 2 in Inaba et al . [2]) .1406
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TABLE I
Clustering ofDendriticandAntigen-responsive CD4+ Cells Early in
the MLR
(C x D2)F, DC, labeled with a carbocyanine dye (18), and B6.H-2k Lyt-
2- Tcellswere cultured 24 hin 16-mm wells. Thecultures were separated
on Percoli velocity gradients into cluster and noncluster fractions repre-
senting 9 and 91 % of the viable cells per culture. Dye-labeled DC corre-
sponded to 5% of the clustered cells and <0.1% of the nonclusters. 3 x
10' clustered cells, 2 x 105 nonclusters, or mixtures of clusters and
nonclusters were cultured in microtest wells at the indicated cell doses.
Proliferative activity was measured at daily intervalsaftera pulse of I 'Ci
['H]TdR in 0.2 ml. The first time (36-48 h) is 12-24 h after separating
the clusters. The experiment was repeated with similar results in the
reciprocal strain combination.
Anti-LFA-1 and CD4 Block Proliferation but Not Cluster Formation in the
MLR. A large panel of previously defined mAb were tested as inhibitors of
lymphocyte proliferation and cluster development in the MLR. Only mAb to
LFA-1, CD4, and class II MHC products inhibited proliferation and IL-2
production (Table 11). Higher doses of DC partially overcame the block (Table
I1). The addition of mAb to LFA-1 and CD4 did not alter the number of
clustered DC or T lymphocytes early in the MLR (Fig. 2, top and Table III).
Therefore it seemed that LFA-I and CD4 were somehow involved in the MLR,
but not in the early stages of DC-T clustering.
Effects of mAb on the Function ofDC-T Clusters.
￿
To measure the clustering of
antigen-specific cells, we first examined the proliferative response ofaggregates
that had formed in the presence of mAb during the first day of the MLR. If
clusters had formed for 24 h in the presence of anti-LFA-1 and were then
washed, a normal proliferative response was observed (Table III). Some reduc-
tion in proliferative activity was observed if clusters were isolated after 40 h of
culture with anti-LFA-1. Therefore anti-LFA-1 did not block the efficient
clustering ofantigen-specific cells with DC at the onset ofthe MLR.
When anti-CD4 was added for 24 h and then the cells were washed, clusters
that had formed in the presence of mAb exhibited 25-50% of the proliferative
activity of controls (Table III). We suspect that anti-CD4 (remaining on the T
cells after washing) was acting after, rather than during clustering, because
additional experiments to be described below indicated that anti-CD4 did not
interfere with the binding ofDC to antigen-specific T cells.
Although anti-LFA-1 did not block DC-T cell clustering, aggregates that had
formed in the presence ofmAb were easily disassembled by gentle pipetting(Fig.
2, bottom). The aggregates did not reform upon further culture. Clusters that
Time of Proliferative response (cpm x 10')
proliferation
measurement (h) Clusters Nonclusters Mix
36-48 40.0 0.8 50.2
60-72 88.4 0.7 69.9
84-96 144.8 0.5 161.1
108-120 59.8 0.7 66.9
132-144 13.5 1.0 22.0TABLE II
Inhibition of T Cell Proliferation and IL-2 Production by mAb Added to the PrimaryMLR
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Graded dosesof DC were added to 3 X 10', Ia Lyt-2-T cells in the presence of the indicated mAb
(hybridoma culture supernatants added at two doses). At 48 h (Exp. 1) or 96 h (Exp. 2), 50 kl of
medium was removed and added to 50 pl of Con A lymphoblasts to measure growth factor (IL-2)
activity. None ofthemAbinhibited theeffect ofIL-2 in thebioassay. At 88-96h, 1 IACi of ['H]TdR
was added to monitor the MLR. Maximal response in the IL-2 bioassay (to 10 U/ml human rIL-2)
was 92 X 10' cpm. The T cell only responses were <200 cpm. The following mAb (ATCC) were
tested but did not reduce or enhance proliferation or IL-2 release: 53-7.1 (CD5); 53-6.7 (CD8); KJ
16 (Ti); 33D1 (DC); MI/70 (C36iR); M1/9.3 (leukocyte); B5-3 (Thy-1).
had formed in the presence of anti-CD4 were not disaggregated by pipetting
(Fig. 2, bottom).
In the next experiments, clusters were generated in the absence of mAb, and
then mAb were added at varying times. Anti-LFA-1 had to be added shortly
after cluster formation to achievea profound block; the block wasmuch reduced
iftheaddition ofmAb was delayedby 7 h (Table IV) or 5 hinanotherexperiment
(not shown). In each case, the anti-LFA-1 mAb stained the clustered lymphocytes
as evaluated by indirect immunofluorescence. In contrast to LFA-1, mAb to
CD4 and la were markedly inhibitory when added either at 0 or 7 h after cluster
formation (Table IV). Whenever the mAb blocked proliferation, there was a
marked reduction of IL-2 activity in the medium (not shown).
When isolated clusters were examined in an inverted microscope, many ofthe
DC-T clusters slowly disassembled in the presence of anti-LFA-l. Yet many of
the disaggregated cells were large blasts (Fig. 3). Anti-CD4 did not dissassemble
the clusters, but few lymphoblasts were produced in or around the cluster (Fig.
3).
We conclude that anti-LFA-1 primarily interferes with the stability rather than
mAb
(antigen/
hybridoma) (%
Dose
Growth
3 X 10"
Response to graded doses dendriticcells
(cpm X 10'' at 88-96 h) IL-2 (cpm X 10-' at 48 h)
10' 3 X 10' 10' 3 X 10' 10' 3 X 10' 10'
Exp. 1: C X D2 (H-2d) anti-B6.H-2k
None 60.0 133.1 47.3 14.2 29.5 25.4 2.8 0.5
Anti-CD4 (GK1 .5) 40 38.0 37.0 5.9 0.6 1.9 0.6 0.2 0.2
4 39.5 41 .6 6.0 0.8 11.0 2.0 0.2 0.1
Anti-LFA-1 (F441.8) 40 190.5 16.3 1.1 0.5 5.4 0.5 0.2 0.2
4 244.7 50.0 3.0 1.7 22.0 3.0 0.4 0.2
Anti-I-E (M5/114) 40 58.1 39.0 1.4 0.5 1.6 0.5 0.2 0.1
4 65.6 49.0 3.6 0.7 5.0 1.0 0.3 0.1
Anti-H-2K(M1/42) 40 74.7 128.4 56.5 15.1 45.2 27.6 2.5 0.2
Exp. 2: B.6 H-2k anti-(C X D2), (H-2d)
None 298.7 240.7 110.8 19.9 55.9 38.8 9.3 1.1
Anti-CD4 (GK1 .5) 25 56.7 20.4 6.1 2.2 2.3 0.5 0.3 0.2
2.5 101.8 35.3 8.3 3.1 6.6 1.1 0.2 0.2
Anti-LFA-1 (F441.8) 25 51 .7 25.1 3.9 1.0 5.0 1.0 0.2 0.1
2.5 63.9 42.6 12.2 4.0 21.7 10.2 0.3 0.2
Anti-I-A,E (M5/114) 25 18.3 11 .0 2.7 0.8 0.3 0.2 0.1 0.1
2.5 41 .9 16.0 4.3 0.6 0.8 0.3 0.1 0.2
Anti-H-2K(M1/42) 25 281.9 245.5 131.6 23.3 35 .1 29.4 15.3 0.6
2.5 289.8 256.4 108.8 27 .2 48.4 24.8 7.4 0.51408
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FIGURE 2 .
￿
Formation ofDC-CD4 clusters in the presence of mAb . The top row contains
micrographs ofthe primary MLRat 24 h and shows the normal development of cell clusters
in the presence ofanti-LFA-1 and-CD4 mAb . Quantitative data on the number of DC andT
cells in the cluster fraction are given in Table III . On the bottom is the appearance of the
same cultures 1 h after the cells were gently resuspended by aspirating and discharging half
of the culture in an Eppendorfpipette three times . The clusters whichformed in the presence
of anti-LFA-1 were easily dissociated and did not reassemble . X75 .
the formation of the DC-T cluster, whereas anti-CD4 primarily retards blasto-
genesis and IL-2 release of clustered T cells .
Effects of mAb on the Binding ofDC to Sensitized, Antigen-specoc T Cells .
￿
To
study antigen-specificT cells more directly, we isolated blasts from MLR clusters
at day 4 and cultured in the absence of IL-2 andAPC to provide memory cells
(3, 17) . Prior work had shown that blasts and memory T cells were >80%
antigen-specific in rapid binding assays (5) . In these assays, the T cells were
tagged with a fluorescent dye and sedimented with graded doses of DC . After
an additional 10 min, nonclustered fluorescent cells were counted . mAb were
added to T blasts and memory cells for 1 h (either at 4 or 37 0C) before mixing
with DC, or during the binding assays . The results were similar regardless of the
method of antibody addition .
mAb to class 11MHC products (reactivity with both I-A and I-E was necessary)INABA AND STEINMAN
TABLE III
Anti-LFA-1 and Anti-CD4 mAb Do Not Inhibit the Formation of
DC-T Clusters Early in the MLR
5 x 10' B6.H-2k DC (labeled with a fluorescent carbocyanine dye, [18])
were used to stimulate 5 x 106 Ia, Lyt-2- H-2d T cells for 24 or 40 h
with and without mAb. Cluster and noncluster fractions from a pool of
four cultures were isolated by velocity sedimentation. The number ofcells
(DC + T) and dye-labeled DC were measured in a hemocytometer. 3 x
10' clustered cells were then cultured in microtest wells with and without
mAb at 40% (vol/vol). [sH]TdR uptake was measured at 88-96 h. The
experiment was repeated with similar results in the reciprocal strain
combination.
TABLE IV
Anti-LFA-1 Has to Be Added Shortly after Cluster Formation to
Block T Cell Proliferation
5 x 10' H-2d DC were used to stimulate 5 x 106 Ia Lyt-2- H-2k T cells
for 20 h. Clusters were isolated and cultured with and without mAb. mAb
were added at 20 h (immediately after the isolation of clusters) or 27 h.
[sH]TdR uptake was measured at the indicated times. Several mAb were
used as controls (anti-Lyt-2, Thy-1, Mac-1, leukocyte, and H-2K) and had
no blocking effects.
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profoundly blocked antigen-dependent binding at 4'C (Table V). The anti-Ti
(T cell receptor for antigen) reagent KJ16 blocked to a lesser extent (Table V),
presumably because only 20% of T cells expressed the KJ16 antigen (19). None
Stimulating
antibody
Total cells x 10'6 (%DC
in parentheses)
Clusters Noncluster
T cell growth (cpm [sH]TdR)
No body anti LFA-1 CD4
At 0-24 h:
mAb given at 24-96 h:
None 0.60 (4.0) 13.2(0) 69.7 10.8 4.0
LFA-1 0.52 (5.3) 12.8(0) 65.1 4.1 2.8
CD4 0.53 (4.3) 13.1(0) 27.3 3 .1 2 .7
mAb given at 40-96 h:
At 0-40 h:
None 0.68 11.5 125.1 112.2 31 .4
LFA-1 0.43 12.2 72.0 6.1 15.6
CD4 0.44 10.9 32.5 3.1 3.1
mAb added
[sH]TdR uptake
68-80 h 92-104 h
cpm
At 20 h:
None 33.0 78.8
CD4 3.9 6.5
LFA-1 5.1 7.1
la 3.3 4.4
At 27 h:
None 33.0 78.8
CD4 4.1 9.3
LFA-1 22.4 65.2
la 7.2 8.51410
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FIGURE 3.
￿
Effect ofmAb on DC-T aggregates . At 20 h of a control MLR, DC-T clusters
were isolated by velocity sedimentation and cultured 20 h more in the presence ofmAb . The
no mAb controls (or several noninhibitory mAb, see Table I legend) contain spherical
aggregates composed of many large lymphoblasts . The latter are distinguished as large clear
profiles around the rim of the clusters. In the presence ofanti-CD4, the clusters remain intact
but there is no blastogenesis . In the presence of anti-LFA-1, the clusters appear smaller and
flatter (DC in the cluster probably do not disassemble) . Note thenumerous single lymphoblasts
that are released by LFA-1 . X75 .
of the other mAb that reacted with T cells or with DC blocked clustering,
including anti-LFA-1 and anti-CD4 .
To assess the capacity of DC to bind in an antigen-independent fashion, we
mixedalloreactive blasts with syngeneic DC at 37°C (5). None of the antibodies,
including anti-I-A and -I-E, blocked antigen-independent binding (Table V) .
Conjugates that were formed with T cells that had been precoated with anti-
LFA-1 were readily dissociated by gentle pipetting ; conjugates formed with anti-
C134-coatedT cells were as stable as controls (not shown) . Therefore, the results
from these rapid binding assays suggest that anti-LFA-1 and -CD4 were not
acting on the initial steps whereby DC bound to T cells .
Effects ofmAb on IL-2 Release and Responsiveness ofSensitized T Cells .
￿
T blasts
were coated with mAb, allowed to bind to DC at 37°C (Table V), and returned
to culture . Microscopic examination of the live cultures revealed that lympho-
blasts were emerging from the aggregate within 5 h in control and anti-LFA-1-
treated cultures . In the presence of anti-CD4 or anti-la, the clusters remained
intact but the blasts began to revert to smaller lymphocytes. IL-2 release was
detectable within 2 h in control cultures (not shown) and increased progressively
over 5-18 h (Tables VI and VII) . Anti-LFA-1-treated conjugates made normal
levels of IL-2 (unless the cultures were studied at intervals longer than 1 d, not
shown) whereas anti-CD4 and anti-la-coated conjugates made little or no IL-2
(Tables VI and VII) .
The IL-2-responsive, alloreactive lymphoblasts were challenged with graded
doses of exogenous human rIL-2 (0.5-100 U/ml). The proliferative responseINABA AND STEINMAN
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TABLE V
Effects ofmAb on DC-T Clustering
Antigen-specific T blasts and memory cells were isolated from the primary MLR (3, 17). Antigen-
dependent DC-T binding occurred when alloreactive (H-2d anti-H-2k) T cells were mixed with
allogeneic (H-2k) DC at 4°C (top line of the tabular data). There was no binding of syngeneic cells
at 4°C(not shown). At 37°C, DC-T bindingwasantigen-independentbecause allogeneic (H-2k) and
syngeneic (H-2d) DC bound similarly to T cells (5). When a variety of mAb were added to the
binding assay (this experiment), or to the T cells for 1 h before the assay (other experiments), the
only block that was observed was for mAb to Ti (KJ-16) andto la (a mixture ofanti-I-E andanti-l-A
mouse mAb). Thetopfour mAbarerat IgG2aandthebottom ratIgG2b.
was not blocked by any of the mAb we tested, including antibodies to la, LFA-
1, and CD4 (Table VII).
Discussion
It has been observed that DC efficiently cluster Tcells during many immune
responses (1-8; Table 1, Fig. 1). We have used mAb to LFA-1 and CD4 to see
whether these molecules are involved in the DC-T aggregation mechanism, and
if not, why do they inhibit T cell proliferation so profoundly (Table 11)? Our
data indicate that mAb to LFA-1 and CD4 do not block the early steps whereby
DC bind to unprimed or sensitized CD4+ cells but inhibit the function of DC-
C134 conjugates. LFA-1 and CD4 do not seem to be accessory molecules for
binding. Instead they play a subsequent and independent role that influences
most CD4+ cells in the primary response.
The fact that anti-LFA-1 and -CD4 do not block the initial clustering in the
MLR perhaps is not surprising. The available evidence is that clustering with
unprimed Tcells is DC-specific and not observed with other APC (1-6, Fig. 1).
Yet the presumptive ligands for LFA-1 and CD4 are likely to be widely distrib-
uted, in that mAb to these molecules block the binding of CD4+ cytolytic cells
to a variety oftargets (14-I6).
There seem to be at least four interactions that contribute to the onset of a
primary T-dependent immune response in DC-CD4+ lymphocyte aggregates .
Antigen Recognition. Antigen specificity is a major component of cluster
Percentalloreactive Tcells that clusterat stated DC-T ratios
mAb Freshly sensitized T blasts - Rested T memory
Allogeneic
4°C
DC, Syngeneic
DC, 37°C
Allogeneic
4 C
DC, Syngeneic
DC, 37°C
Clone Determinant 1:2 1:10 1:50 1:10 1:2 1:10 1:50 1:10
None None 68 42 15 73 79 51 13 82
14-4-4S I-E 34 16 4 73 38 0.4 0.7 83
+10.216 +I-A
KJ-16 Ti 50 33 11 74 62 26 5 81
M1/42 H-2K 67 41 14 73 79 50 14 80
53-6.7 Lyt-2 69 40 13 74 76 52 13 81
53-7.1 Lyt-1 71 41 16 73 78 52 12 82
GK1.5 L3T4 73 42 12 73 78 55 12 87
115-3 Thy-1 69 42 16 73 80 51 13 82
FD441.8 LFA-1 72 44 18 73 77 55 14 89
M1/70 C3biR 69 42 16 73 85 51 13 811412 SITE OF INHIBITION BY ANTIBODIES TO LFA-1 AND CD4
TABLE VI
Anti-CD4 mAb Blocks IL-2 Releasefrom DC-T Clusters
3 X 10'alloreactive Tblasts were exposed to mAb(30%, vol/vol) for 1 h.
DC of the indicated MHC were added. The cells were sedimented (50 g,
5 min), and DC-T clusters were allowed to form as in TableV. The cells
were resuspended once and cultured in 1 ml of medium for 5 h at 37°C.
Graded aliquots of themedium were assayed for growth factor activity on
Con A T blasts. Data are cpm X 10' at 50% (vol/vol). Half-maximal
activities in the bioassay were 70-55 X 10', respectively. IL-2 activity
without DC was <500 cpm.
Effects ofmAb on TLymphoblasts:IL-2 Release and Responsiveness
TABLE VII
H-2d anti-H-2k Lyt-2- Tblasts were isolated from theprimary MLRand
3 X 10' cells were challenged with human rIL-2. Proliferation is shown
only for the half-maximal dose of IL-2. Otheraliquots of the blasts (3 X
10'cells/well) were challenged with graded dosesofH-2k DC. IL-2 activity
in the medium is shown. Data arecpm X 10-' at 18 h.
function. Antigen-specific blasts are produced in the cluster (2-4), whereas the
noncluster fraction (representing >90% of the cells in the culture) are substan-
tially depleted of antigen reactivity (3). Antigen specificity likely involves the
interaction between Ti molecules on the lymphocyte and MHC products on the
APC (20, 21). At this time, the most direct assay for the Ti-MHC interaction is
the rapid binding assay between sensitized Tcells and DC at VC. C. This assay is
blocked by antibodies to Ti and MHC but not by other mAb to DC or T cells
Exp. 1 IL-2 released (cpm X 10-')
H-2d anti-H-2k T blasts:
mAb DC: H-2k H-2bxd DC-T ratio: 1:10 1:2 1:10
None 26.8 8.2 2.2
I-Ak + I-Ed.k 3.6 1.0 0.8
LFA-la 28.7 7.0 0.6
CD4 0.4 0.4 0.3
T blasts: H-2d anti-H-2k H-2d anti-H-2bxd
Exp. 2 DC: H-2k H-2bxd
DC-T ratio: 1:3 1:3
Response to IL-2 activity released (cpm X 10-') by
half-maximal T blasts in response to graded doses
mAb dose of of DC
human rIL-2 10" 3 X 109 109
None 23.2 57.1 21 .5 5.3
CD4 23.8 18.4 3.6 0.7
LFA-1 24.4 54.8 25.9 3.0
I-A, I-E 24.7 21.2 3.8 0.8
CD8 24.5 57.9 32.4 4.9
None 128.1 87 .0
I-Ak + I-Ed.k 61.3 80.3
LFA-1a 117.3 89.2
CD4 22.7 6.5INABA AND STEINMAN
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including anti-LFA-1 and anti-CD4 (Table V). However, the Ti-MHC interac-
tion may not be the first one between DC and unprimed T cells. Macrophages
andB lymphocytes express the MHC products that are recognized by T cells but
do not cluster as do DC (1-6). Therefore other molecules on DC, or additional
features of DC MHC products, seem necessary for early clustering (see below).
CD4 Function.
￿
The expression of CD4 molecules on peripheral T cells is
tightly associated with the recognition of la glycoproteins (class II MHC prod-
ucts), whereas expression ofCD8 is linked to the recognition ofclass I (22). For
this reason it has been proposed that CD4 interacts with la and contributes to
APC-T cellbinding. Nevertheless, there is data that anti-CD4 blocks mitogenesis
in the apparent absence of la molecules suggesting a signaling rather than la-
binding function (23, 24). The large(45-amino-acid)cytoplasmic domain ofCD4
exhibits marked (78%) similarity in rodents and humans (25, 26) consistent with
a conserved intracellular role.
Our data (Tables III and V; Figs. 2 and 3) indicate that most antigen-responsive
T cells in the MLR bind to DC in the presence of blocking levels of anti-CD4
mAb. However, the effect of anti-CD4 on the ensuing function of DC-T
conjugates is dramatic. IL-2 production immediately ceases (Table VI), and the
blasts revert to smaller memory cells within 3-5 h (not shown). These findings
imply a cell signaling vs. binding function for CD4, in which la could be the
physiologic trigger. The putative interaction of la (or la-associated molecule)
with CD4 may only occurafterpolymorphic la determinants have been engaged
by the Ti/T3 receptor complex.
It has recently been shown that the administration ofanti-CD4 mAb in situ
results in antigen-specific tolerance (27, 28). If CD4+ T cells see antigen to be
tolerized, then these in situ results support our in vitro findings that APC can
efficiently bind to specific T cells in the presence ofanti-CD4 (Table V).
LFA-1.
￿
A third DC-T interaction mechanism involves LFA-1 . A ligand for
LFA-I is not yetidentified. Anti-LFA-1 does notappear to block the initial stages
of the DC-T interaction (Tables III, V-VII) but significantly inhibits other
aspects. Ifclusters ofDC and either unprimed (Fig. 2) or primed (not shown) T
cells are gently resuspended, the clusters dissociate and do not reform. When
anti-LFA-1 is added to recently formed primary clusters, the mAb slowly (4-20
h) disassembles the aggregates and markedly reduces subsequent proliferation
(Fig. 3; Table IV). Prior studies in which activated Tcells have been mixed with
APC have concluded that anti-LFA-1 has either a modest (9, 29) or large (30)
effect on conjugate formation. A critical variable in these experiments may be
the vigor with which the conjugates are resuspended before measurement.
Another variable is that prior work has not used DC. It is possible that other
APC are more dependent on LFA-I for the initial APC-T binding step.
Although our observations indicate that LFA-1 contributes to the stability of
DC-CD4 conjugates, the molecule may have other effects. The C3bi receptor,
which is a member ofthe LFA-1 family, has both binding and signaling functions
which are regulated independently (31). We are finding that DC-T aggregates
contain many antigen-nonspecific cells early in the MLR (8-24 h) but exclude
nonspecific cells later on (48-72 h; Freudenthal, manuscript in preparation).
LFA-1, once engaged, may signal the DC or T cell to turn off the antigen-1414
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nonspecific binding mechanism that brings DC and T cells together (see below).
DC-T clusters once dissociated do not recluster in the presence ofanti-LFA-1 .
LFA-I is expressed on resting T cells, but it only seems to influence binding
after the T cell has interacted with DC. The adhesion function of LFA-1
therefore may be regulated independently of its levels of expression. A similar
phenomenon has been noted in studies ofthe C3bi receptor, a member of the
LFA-1 family that usesa common 90-kD /3 chain. The binding function ofC3biR
is reduced when monocytes are cultured in IFN-,y, without major changes in the
expression of this molecule (31).
Our observations may explain why patients who lack LFA-1 do not exhibit a
profound clinical T cell deficiency (32). Antigen recognition (Table V), blasto-
genesis (Fig. 3), and IL-2 release (TablesVI and VII)all may begin in the absence
of LFA-1, but a prolonged DC-T interaction will not occur. Patients may
therefore have sufficient T cell function to avoid symptoms.
Antigen-independent DC-T Cell Binding. A fourth interaction mechanism
could be critical for cluster formation in the primary response. We suspect that
DC use a unique adhesion molecule to reversibly sample or survey T cells.
Binding would be stabilized when complementary MHC and Ti molecules on
DC and Tcells interact. There are three reasons for postulating a distinct, early
DC-T cell interaction mechanism that is required for antigen-specific responses.
First, the Ti-MHC interaction does not initself seemtoinitiate clusterformation,
since many types of APC express MHC molecules but do not form clusters.
Second, clear-cut antigen-independent DC-T binding is evident in rapid binding
assays, particularly with sensitized T cells where the antigen-specificity of the
lymphocyte is known (5). APC that do not initiate primary responses-such as
macrophages, B lymphocytes, andfreshly isolated Langerhans cells-do notbind
T cells in the absence ofantigen (5, 33). Third, none of the existing mAb to DC
or to T cells, including anti-LFA-1 and -CD4, blockantigen-independentbinding
(Tables III and V). Recent studies in the human MLR (Freudenthal et al.,
manuscript in preparation) indicate thatantigen-nonspecific Tcells rapidly enter
and leave the DC-T aggregate while simultaneously, specific lymphocytes are
selected and induced to proliferate.
Summary
T cell proliferation in response to many stimuli is known to occur in discrete
clusters of dendritic cells (DC) and CD4+ helper lymphocytes. The role of
lymphocyte function-associated antigen (LFA-1) and CD4 in the formation and
function of these clusters has been evaluated in the mixed leukocyte reaction
(MLR).
By day 1 of the control MLR, most of the DC and responsive T cells are
associated in discrete aggregates. Addition ofanti-LFA-1 and CD4 reagentsdoes
not block DC-T aggregation but reduces the subsequent proliferative response
by 80-90%. Anti-LFA-1 disassembles newly formed DC-T cell aggregates,
whereas anti-CD4 inhibits blastogenesis without disrupting the cluster.
Binding of DC to sensitized, antigen-specific CD4' cells has been studied using
lymphoblasts isolated at day 4 of the MLR. It has been shown previously that
>80% blasts rebind to DC in an antigen-specific fashion in rapid (10 min) bindingassays. Antigen-dependent DC-T binding is blocked by anti-la but not by mAb
to LFA-1 or CD4. However, the bound anti-CD4-coated lymphocytes are unable
to release IL-2. Anti-LFA-1-coated T cells release IL-2 but are easily disaggre-
gated after binding to DC.
These findings lead to two conclusions. LFA-1 and CD4 are not involved in
the initial steps whereby DC bind to T cells but exert an independent and
subsequent role. LFA-1 acts to stabilize the DC-T cluster, while CD4 contributes
to lymphocyte blastogenesis and IL-2 release. Because DC but not other pre-
senting cells cluster unprimed lymphocytes, it seems likely that an antigen-
independent mechanism distinct from LFA-1 and CD4 mediates aggregate
formation at the onset of cell-mediated immunity.
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